A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients

This study aimed to validate the long-term prognostic value of a new clinical-genomic model, Distant Genetic Model-Clinical Variable Model 6 (DGM-CM6), developed in Asia as a prognostic panel for all subtypes of breast cancer. We included 752 operable stage I–III breast cancer patients representing...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Tzu-Ting, Lei, Lei, Chen, Ching-Hsuan Andre, Lu, Tzu-Pin, Jen, Chung-Wen, Cheng, Skye Hung-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078190/
https://www.ncbi.nlm.nih.gov/pubmed/32184406
http://dx.doi.org/10.1038/s41598-020-61535-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078190/
https://www.ncbi.nlm.nih.gov/pubmed/32184406
http://dx.doi.org/10.1038/s41598-020-61535-9

Ejemplares similares